Viewing Study NCT00842894


Ignite Creation Date: 2025-12-25 @ 1:31 AM
Ignite Modification Date: 2025-12-29 @ 12:24 AM
Study NCT ID: NCT00842894
Status: COMPLETED
Last Update Posted: 2014-08-15
First Post: 2009-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in Macedonia
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module